globotriaosylceramide has been researched along with Cell-Transformation--Neoplastic* in 2 studies
2 other study(ies) available for globotriaosylceramide and Cell-Transformation--Neoplastic
Article | Year |
---|---|
The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer.
The most devastating aspect of cancer is the emergence of metastases. Thus, identification of potentially metastatic cells among a tumor cell population and the underlying molecular changes that switch cells to a metastatic state are among the most important issues in cancer biology. Here we show that, although normal human colonic epithelial cells lack the glycosphingolipid globotriaosylceramide (Gb(3)), this molecule is highly expressed in metastatic colon cancer. In addition, a subpopulation of cells that are greatly enriched in Gb(3) and have an invasive phenotype was identified in human colon cancer cell lines. In epithelial cells in culture, Gb(3) was necessary and sufficient for cell invasiveness. Transfection of Gb(3) synthase, resulting in Gb(3) expression in noncancerous polarized epithelial cells lacking endogenous Gb(3), induced cell invasiveness. Furthermore, Gb(3) knockdown by small inhibitory RNA in colon cancer epithelial cells inhibited cell invasiveness. Gb(3) is the plasma membrane receptor for Shiga toxin 1. The noncatalytic B subunit of Shiga toxin 1 causes apoptosis of human colon cancer cells expressing Gb(3). Injections of the B subunit of Shiga toxin 1 into HT29 human colon cancer cells engrafted into the flanks of nude mice inhibited tumor growth. These data demonstrate the appearance of a subpopulation of Gb(3) containing epithelial cells in the metastatic stage of human colon cancer and suggest their possible role in colon cancer invasiveness. Topics: Animals; Caco-2 Cells; Cell Line, Tumor; Cell Transformation, Neoplastic; Colonic Neoplasms; Epithelial Cells; Galactosyltransferases; Glycosphingolipids; Humans; Lasers; Mice; Mice, Nude; Microscopy, Confocal; Microscopy, Fluorescence; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Phenotype; Pseudopodia; Shiga Toxins; Trihexosylceramides | 2005 |
A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody.
The antigen defined by a rat monoclonal antibody directed to a Burkitt lymphoma cell line was identified as globotriaosylceramide [Gal alpha (1 leads to 4)-Gal beta (1 leads to 4)-Glc beta (1 leads to 1)-ceramide]. The antibody demonstrated a strict steric specificity since it did not react with globoisotriaosylceramide [Gal alpha (1 leads to 3)-Gal beta (1 leads to 4)-Glc beta (1 leads to 1)-ceramide], the positional isomer of the antigen associated with the Burkitt lymphoma. Chemical analysis of various Burkitt lymphoma cell lines revealed that the Burkitt lymphoma cells contained more than 100 times as much of the glycolipid antigen as was found in other human lymphoma and leukemia cell lines. Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Burkitt Lymphoma; Cell Line; Cell Transformation, Neoplastic; Erythrocytes; Globosides; Glycosphingolipids; Humans; Rabbits; Rats; Trihexosylceramides | 1983 |